Soumya Poddar^1*, Jiali Yan^2*, Gayatri Tiwari^2*, Darawan Rinchai^3*, Wangshu Zhang, PhD^4*, Justin Budka^5*, Weixin Peng, MS^4*, Shruti Salunkhe^6*, Madison Davis^3*, Qinghua Song, PhD^6*, Sara Beygi, MD^4*, Harry Miao, MD, PhD⁴, Mike Mattie, PhD^6*, Rhine Shen, PhD^4*, Caron A. Jacobson, MD, MMSc⁷, Davide Bedognetti, MD^8*, Simone Filosto, PhD^4* and Sattva S. Neelapu, MD⁹

¹Kite, a Gilead Company, Agoura Hills, CA
²Kite Pharma, a Gilead Company, Santa Monica, CA
³Kite Pharma, Santa Monica
⁴Kite, a Gilead Company, Santa Monica, CA
⁵Kite, A Gilead Company, Santa Monica, CA
⁶Kite Pharma, a Gilead company, Santa Monica, CA
⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Kite Pharma, Santa Monica, CA
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Shengqin Su^1*, Ajay Subramanian^2*, Timothy Flerlage, MD^3,4*, Jamie E. Flerlage, MD, MS^3,4, Cedric Rossi, MD, PhD^5,6, Troy Noordenbos^7*, Joseph G. Schroers-Martin, MD⁷, Everett J. Moding, MD, PhD^2*, Richard T. Hoppe, MD², Ranjana H. Advani, MD⁸, Yasodha Natkunam, MD, PhD⁹, Ash A. Alizadeh, MD, PhD¹⁰ and Michael S. Binkley, MD, MS^2*

¹Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
²Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
³Department of Pediatrics, University of Rochester, Rochester, NY
⁴Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁵CHU Dijon, DIJON, France
⁶Stanford University, Stanford, CA
⁷Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁸Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
⁹Department of Pathology, Stanford University School of Medicine, Stanford, CA
¹⁰Stanford University, San Mateo, CA

Haris Babačić, MD, PhD^1*, Nashif Mahruf Chowdhury, MD^2*, Mattias Berglund, PhD^3*, Jamileh Hashemi, PhD^2*, Jeremia Collin, MD^2*, Emma Pettersson, MD^2*, Ann-Marie Ly, MD^4*, Anna Nikkarinen, MD^5*, Gunilla Enblad, MD, PhD^3*, Daniel Molin^3*, Ingrid Glimelius, MD, PhD^4,5, Maria Pernemalm, PhD^6* and Mats Hellström, MD, PhD^3*

¹Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden
²Dept of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
³Department of Immunology, Genetics and Pathology, Cancer Immunotherapy Unit, Uppsala University, Uppsala, Sweden
⁴Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden., Uppsala University, Uppsala, Sweden
⁵Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden
⁶Department of Oncology-Pathology, Science for Life Laboratory,, Karolinska Institutet, Stockholm, Sweden

Yuanfeng Wang^1*, Satishkumar Singh, PhD², Audrey Odier^2*, Alessandro La Ferlita, Ph.D^3*, Wing Chan, PhD⁴, Maxine Berger^5*, Sriya Sreekanth^3*, Narendranath Epperla, MD, MS⁶, Natarajan Muthusamy, PhD, DVM⁷, Robert Baiocchi, MD, PhD⁸, Lapo Alinari, MD, Ph.D⁹, Mamta Gupta, PhD¹⁰ and Lalit Sehgal, PhD^4,11

¹Division of Hematology, College of Medicine, The Ohio State University, Columubs, OH
²Division of Hematology, College of Medicine., The Ohio State University, Columbus, OH
³Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
⁴James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁵Division of Hematology, College Of Medicine, The Ohio State University, Columbus, OH
⁶Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁷The Ohio State University, Columbus, OH
⁸Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus
¹⁰Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC
¹¹Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH

Shanshan Zhang^1*, Zhang Hanzhen^2*, Chen Huan^3*, Yuqi Wang^4*, Youhai Yuan^5*, Xiaolei Wei, MD^6* and Qifa Liu, MD⁷

¹Department of Hematology, Department of Hematology, Nanfang Hospital, Southern medical university, Guangzhou, China
²Department of Hematology, Nanfang Hospital, Southern Medical University, Guangdong, China
³Southern Medical University, GuangZhou, China
⁴Nanfang hospital, Guangzhou, AL, China
⁵Nanfang hospital, Guangzhou, China
⁶Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
⁷Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Claudia Kettlun, PhD^1*, Daniel Galvan, PhD^1*, Jie Xu, MD PhD^2*, Tania P Sainz Zuniga^1*, Sebastian Juarez-Casillas^1*, Daisy Y. Diaz Rohena, BS³, Vishal Sahu, PhD^1*, Juan Andres Donoso^1*, Arrate Zubero^1*, Estela Rojas-Neira^4*, David Blake, PhD^5*, Jared Henderson, PhD^6*, Michael Green, PhD⁷, Tapan M. Kadia, MD⁸, Deepa Sampath, PhD⁹ and Francisco Vega, MD, PhD¹⁰

¹Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Cyclacel Limited, Dundee, GBR
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰MD Anderson Cancer Center , Houston, TX

Julia C. Kuehn, MD^1*, Nicolas N. Neidert, MD^2*, Junyi Zhang^2*, Jurik A Mutter, PhD^3*, Stefan K. Alig, MD⁴, Christian Klingler, PhD^5*, Fabian Hummel^1*, Sabine Bleul^1*, Lavanya Ranganathan^5*, Jürgen Beck, MD^2*, Marco Prinz, MD^6,7,8*, Maximilian Diehn, MD, PhD^9*, Ash A. Alizadeh, MD, PhD³, Justus Duyster, MD^10*, Roman Sankowski, MD^11*, Dieter Henrik Heiland, MD^12* and Florian Scherer, MD^1,13

¹Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
³Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁴Divisions of Oncology and Hematology, Stanford University School of Medicine, Stanford, CA
⁵Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
⁶Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁷Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany
⁸Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany
⁹Department of Radiation Oncology, Stanford University, Stanford, CA
¹⁰Department of Medicine I, Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
¹¹Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, DEU
¹²Department of Neurosurgery,, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
¹³German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany

Xiaoyan Feng, MD^1*, Miaomiao Meng^2*, Zhenchang Sun^3*, Xudong Zhang^1*, Lei Zhang^4* and Mingzhi Zhang, MD⁵

¹Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
²Academy of Medical Sciences of Zhengzhou University, Zhengzhou, China
³The First Affiliated Hospital of Zhengzhou Univeristy, Zhengzhou, China
⁴Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁵The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Rachel Koldej, PhD^1,2, Allison Barraclough, MBBS, BSc, FRACP, FRCPA³, Sze Ting Lee, MBBS, FRACP, FAANMS, PhD^4*, Huw Morgan^5*, Nicholas Holzwart^5*, Minu Koshy^6*, Charmaine Smith^7*, Geoffrey Chong^8*, Michael Gilbertson, MBBS (Hons), FRACP, FRCPA⁹, Colm Keane, MD¹⁰, Denise Lee, MBBS^11*, Leonid Churilov, PhD^12*, David S. Ritchie, MBChB PhD^1,2,13 and Eliza A. Hawkes, MD¹⁴

¹ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
²Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
³Fiona Stanley Hospital, Perth, Australia
⁴Dept Molecular Imaging and Therapeutics, Austin Health, Melbourne, Australia
⁵Royal Melbourne Hospital, Melbourne, AUS
⁶Dept Pathology, Austin Health, Heidelberg, Australia
⁷Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, VIC, Australia
⁸Olivia Newton-John Cancer Centre, Heidelberg, VIC, Australia
⁹Department of Clinical Haematology, Monash Health, Clayton, AUS
¹⁰Mater Research, University of Queensland, Translational Research Institute, Brisbane, Australia
¹¹Eastern Health, Box Hill, Australia
¹²Melbourne Medical School, University of Melbourne, Parkville, Victoria, AUS
¹³Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
¹⁴Olivia Newton John Cancer Research Institute at Austin Health and Monash University, Melbourne, VIC, Australia

Penny Q. Fang^1*, Susan Y. Wu^2*, Jillian R. Gunther, MD, PhD^1*, Alena Frank, MS^3*, Pavel Zemskiy, MS^4*, Aleksandr Zaitsev, MS^5*, Evgenii S Bolshakov, PhD^5*, Anastasiya Terenteva, PharmD^5*, Krystle Nomie, PhD^4*, Michelly Abreu^6*, Karla Ow^6*, Minifrida Santiago^6*, Jaimole Varghese^6*, Amy Ayers, MPH^6*, Jared Henderson, PhD^7*, Sairah Ahmed, MD⁸, Jason R. Westin, MD⁸, Christopher R. Flowers, MD, MS⁸, Sattva S. Neelapu, MD⁶, Bouthaina S. Dabaja, MD^9*, Chelsea C. Pinnix, MD, PhD¹ and Paolo Strati, MD⁸

¹Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
²Radiation Oncology, MD Anderson Cancer Center, Houston, TX
³BostonGene, Waltham, MA
⁴BostonGene Corp., Waltham, MA
⁵BostonGene, Corp., Waltham, MA
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX

Hui Jin, MD^1*, Ling Wang^1*, Yimin Ren^1*, Zijuan Wu, MD^2*, Wenyu Shi^3* and Jianyong Li, MD⁴

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
²Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, AL, China
³Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
⁴Pukou CLL Center, Pukou Division of Jiangsu Province Hospital, Nanjing, China

Zhijuan Lin, MD^1*, Xingxing Yu^2*, Yan Hong^2*, Long Liu^2*, Jie Zha^2* and Bing Xu²

¹Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
²Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Fujian, China

A. De Jonge^1,2*, Troy Noordenbos^3,4*, Ruben A.L. De Groen, MSc^5*, Fleur A. De Groot^6*, Lorraine M. De Haan-Treurniet, MD^4*, Patty M. Jansen, MD^4*, Liping Fu^7*, Koen de Heer, MD, PhD^8*, Clara Klerk, MD PhD^9*, Yorick Sandberg, MD PhD^10*, Rob Fijnheer, MD PhD^11*, Pim Mutsaers, MD^12*, Aart Beeker, MD¹³, Lara H. Böhmer, MD^14*, Steven Wang, MD^15*, Leonie Strobbe, MD^16*, Rinske Boersma, MD^17*, Margriet Oosterveld, MD^18*, Harry R. Koene, MD PhD^19*, Noel De Miranda^6*, Anke Van Den Berg, PhD²⁰, Marcel Nijland, MD, PhD^21*, Margaretha G.M. Roemer, PhD^22*, Tuna Mutis, MD PhD^23,24*, Martine E.D. Chamuleau, MD PhD^1,24 and Joost S.P. Vermaat²⁵

¹Department of Hematology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²Cancer Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
³Stanford Cancer Institute, Stanford University, Stanford, CA
⁴Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
⁵Leiden University Medical Center, Leiden, Netherlands
⁶Leiden University Medical Center, Leiden, NLD
⁷HOVON Pathology Facility and Biobank (HOP), Amsterdam, Netherlands
⁸Department of Internal Medicine, Flevoziekenhuis, Almere, Netherlands
⁹Department of Internal Medicine, Dijklanderziekenhuis, Hoorn, Netherlands
¹⁰Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands
¹¹Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, Netherlands
¹²Pim Mutsaers, Rotterdam, Netherlands
¹³Spaarne Ziekenhuis, Hoofddorp, Netherlands
¹⁴Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
¹⁵Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, Netherlands
¹⁶Department of Internal Medicine, Gelreziekenhuizen, Zutphen, Netherlands
¹⁷Department of Internal Medicine, Amphia Ziekenhuis, Breda, Netherlands
¹⁸Canisius-Wilhelmina Hospital, Nijmegen, NLD
¹⁹St. Antonius Hospital, Nieuwegein, NLD
²⁰Department of Pathology and Medical Biology, Univ. Med. Center Groningen, Groningen, NLD
²¹University Medical Center Groningen and University of Groningen, Groningen, Netherlands
²²Amsterdam UMC Location Vrije Universiteit, Amsterdam, Netherlands
²³Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²⁴Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
²⁵Department of Hematology, Leiden University Medical Center, Leiden, Netherlands

Jimena B. Gimenez, MD^1*, Min Shi, MD, PhD^1*, Naoki Oishi, MD, PhD^2*, Liuyan Jiang, MD^3*, Farah M. Salama^1*, Jennifer R. Chapman-Fredricks, MD^4*, Weina Chen, MD, PhD^5*, Jagmohan Sidhu^6*, Xiaojun Wu, MD, PhD^7*, Stephen M. Ansell, MD, PhD⁸, Guangzhen Hu, PhD^1* and Andrew L. Feldman, MD¹

¹Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, MN
²Department of Pathology, University of Yamanashi, Chuo, JPN
³Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Jacksonville
⁴Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL
⁵Department of Pathology, UT Southwestern Medical Center, Dallas, TX
⁶Department of Pathology and Laboratory Medicine, United Health Services, Binghamton, NY
⁷Department of Pathology, Johns Hopkins Medicine, Baltimore, MD
⁸Division of Hematology, Mayo Clinic, Rochester, MN

Paul R Buckley^1*, Julie Chan, PhD^2*, Cynthia Bishop, PhD^3*, Timothy Woo, MD^4*, Katrina Todd^5*, Elizabeth Phillips, MD⁶, Alessia Bottos, PhD^7*, Christopher R. Bolen, PhD^8*, Verena Passerini, PhD^9*, Oliver Weigert, MD^10,11 and Piers E.M. Patten, MBChB, FRCP, FRCPath, PhD^12,13*

¹Comprehensive Cancer Centre, King's College London / GSTT, London, United Kingdom
²King's College London, London, United Kingdom
³Guy's Hospital, Guy's & St Thomas NHS Foundation Trust, London, United Kingdom
⁴King's College London / KCH, London, United Kingdom
⁵Guy's & St Thomas NHS Foundation Trust, London, United Kingdom
⁶The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom
⁷F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁸Genentech, Inc., South San Francisco, CA
⁹Department of Medicine III, Hospital of the Ludwig-Maximilians-University (LMU), Munich, Germany
¹⁰Department of Internal Medicine III, University of Munich, Munich, Germany
¹¹Experimental Leukemia and Lymphoma Research (ELLF), University Hospital, LMU Munich, Munich, Germany
¹²Comprehensive Cancer Centre, King's College London, London, United Kingdom
¹³King's College Hospital, London, United Kingdom

Peter-Martin Bruch, MD^1,2,3,4*, Christina Schniederjohann^3,5,6,7*, Harald Voehringer, PhD^4,7,8*, Matthias Meyer-Bender^4,9*, Sarah Koziel^3,4,10*, Lisa-Maria Held^3,10*, Erin Kim Chung^4,9*, Hilka Rauert-Wunderlich^11*, Marita Ziepert, PhD^12*, Norbert Gattermann, MD¹³, Gerhard Held, MD^14,15*, German Ott, MD^16*, Andreas Rosenwald, MD^17*, Wolfgang Huber^4,18* and Sascha Dietrich, MD^3,4,19,20*

¹Department of Hematology, Oncology and Clinical Immunology, Düsseldorf University Hospital, Düsseldorf, Germany
²Heidelberg University Hospital, Heidelberg, Germany
³Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Düsseldorf, Germany
⁴Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany
⁵1. Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, DEU
⁶Molecular Medicine Partnership Unit (MMPU), Düsseldorf, Germany
⁷Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁸European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⁹European Molecular Biology Laboratory, Heidelberg, Germany
¹⁰Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany
¹¹Institute of Pathology, University of Wuerzburg, Wuerzburg, DEU
¹²Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
¹³Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany
¹⁴Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany
¹⁵Universitätsklinikum des Saarlandes, Homburg, DEU
¹⁶Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
¹⁷Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
¹⁸Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
¹⁹Department of Hematology, Oncology and Clinical Immunology, University Hospital of Düsseldorf, Düsseldorf, Germany
²⁰Heidelberg University Hospital, Heidelberg, DEU

Joanne Elizabeth Davis, PhD^1*, Lina HH Le^2*, Mandy Ludford-Menting^2*, Nicholas Holzwart^3*, Sasanka M Handunnetti, MBBS, BPharm, FRACP, FRCPA^4*, Constantine S. Tam, MD, MBBS⁵, Mary Ann Anderson, MBBS, PhD, FRACP, FRCPA^6,7*, David S. Ritchie, MBChB PhD^8,9,10 and Rachel Koldej, PhD^9,10

¹Royal Melbourne Hospital, Melbourne, VIC, AUS
²Royal Melbourne Hospital, Melbourne, Australia
³Royal Melbourne Hospital, Melbourne, AUS
⁴Princess Alexandra Hospital, Brisbane, AUS
⁵Alfred Hospital and University of Melbourne, Melbourne, VIC, Australia
⁶Centre of Excellence for Cellular Immunotherapy and Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
⁷Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
⁸Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁹ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
¹⁰Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia

Tomohiro Aoki, MD, PhD¹, Davidson Zhao^1,2, Noémie Lang, M.D.^3*, Yifan Yin^4*, Ting Liu, PhD^1*, Michael Hong^1*, Johanna Regala^1*, Troy Ketela, PhD^5*, Anca Prica, MD, MSc^6*, John Kuruvilla, MD, FRCPC⁶, Pedro Farinha⁴, Jan Delabie, MD, PhD^7*, Federico Gaiti, PhD⁸, Kerry J. Savage, MD, MSc⁹, David W. Scott, MBChB, PhD⁴ and Robert Kridel, MD, PhD⁶

¹Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Medical Biophysics - University of Toronto, Toronto, Canada
³Division of Oncology, Department of Oncology, Faculty of Medicine, Geneva University Hospital, Geneva, Switzerland
⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁵Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
⁶Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
⁷Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
⁸Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁹BC Cancer, Vancouver, BC, Canada

Ava J Boutilier, MSc, BSc, MA^1,2, Mohammad Raad^2*, Sherine Elsawa, PhD³, Kailey E Paar^2*, Stephan J Matissek, PhD^4*, Cameron E Banks^2*, Allison Carl^2*, Anna D Metzler^2*, Jenna M Murray^2*, Mamta Gupta, PhD⁵, Katja U Koeppen^6* and Michael J. Rauh, MD, PhD⁷

¹Department of Medicine, Queen's University, Kingston, ON, Canada
²Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH
³University of New Hampshire, Durham, NH
⁴Department of Molecular, University of New Hampshire, Durham, NH
⁵Department of Biochemistry and Molecular Medicine, George Washington University, Rochester, MN
⁶Department of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth, Hanover, NH
⁷Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada